title: Effects of ralfinamide, a Na+ channel blocker, on firing properties of nociceptive dorsal root ganglion neurons of adult rats.
abstract: Recent studies revealed that ralfinamide, a Na(+) channel blocker, suppressed tetrodotoxin-resistant Na(+) currents in dorsal root ganglion (DRG) neurons and reduced pain reactions in animal models of inflammatory and neuropathic pain. Here, we investigated the effects of ralfinamide on Na(+) currents; firing properties and action potential (AP) parameters in capsaicin-responsive and -unresponsive DRG neurons from adult rats in the presence of TTX (0.5 microM). Ralfinamide inhibited TTX-resistant Na(+) currents in a frequency- and voltage-dependent manner. Small to medium sized neurons exhibited different firing properties during prolonged depolarizing current pulses (600 ms). One group of neurons fired multiple spikes (tonic), while another group fired four or less APs (phasic). In capsaicin-responsive tonic firing neurons, ralfinamide (25 microM) reduced the number of APs from 10.6+/-1.8 to 2.6+/-0.7 APs/600 ms, whereas in capsaicin-unresponsive tonic neurons, the drug did not significantly change firing (8.4+/-0.9 in control to 6.6+/-2.0 APs/600 ms). In capsaicin-responsive phasic neurons, substance P and 4-aminopyridine induced multiple spikes, an effect that was reversed by ralfinamide (25 microM). In addition to effects on firing, ralfinamide increased the threshold, decreased the overshoot, and increased the rate of rise of the AP. To conclude, ralfinamide suppressed afferent hyperexcitability selectively in capsaicin-responsive, presumably nociceptive neurons, but had no measurable effects on firing in CAPS-unresponsive neurons. The action of ralfinamide to selectively inhibit tonic firing in nociceptive neurons very likely contributes to the effectiveness of the drug in reducing inflammatory and neuropathic pain as well as bladder overactivity.
authors: Department of Pharmacology, University of Pittsburgh School of Medicine, E1304 Biomedical Science Tower, Pittsburgh, PA 15261, USA.
authors: Hana
authors: H
authors: Yamane
authors: William C
authors: WC
authors: de Groat
authors: Adrian
authors: A
authors: Sculptoreanu
mesh_terms: D015761:4-Aminopyridine / Q000494:pharmacology; D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D002211:Capsaicin / Q000494:pharmacology; D004351:Drug Resistance; D004558:Electric Stimulation; D004594:Electrophysiology; D005464:Fluorobenzenes / Q000494:pharmacology*; D005727:Ganglia, Spinal / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D008297:Male; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D009619:Nociceptors / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D018689:Sensory System Agents / Q000494:pharmacology; D026941:Sodium Channel Blockers / Q000494:pharmacology*; D013373:Substance P / Q000494:pharmacology; D013779:Tetrodotoxin / Q000494:pharmacology
chemical_list: D005464:Fluorobenzenes; D018689:Sensory System Agents; D026941:Sodium Channel Blockers; C499681:Ralfinamide; D013373:Substance P; D013779:Tetrodotoxin; D015761:4-Aminopyridine; D002211:Capsaicin
references: Scand J Urol Nephrol Suppl. 1999;201:73-5
references: 10573780
references: Exp Neurol. 2000 Jan;161(1):273-84
references: 10683293
references: Pain. 2000 Dec 15;89(1):47-52
references: 11113292
references: Anesthesiology. 2001 Jan;94(1):137-44
references: 11135733
references: J Neurophysiol. 2001 Aug;86(2):629-40
references: 11495938
references: J Neurosci. 2001 Nov 1;21(21):8690-6
references: 11606657
references: Am J Physiol Gastrointest Liver Physiol. 2002 Jun;282(6):G1045-51
references: 12016130
references: Brain Res. 2003 Feb 14;963(1-2):132-8
references: 12560118
references: Pain. 2003 Mar;102(1-2):17-25
references: 12620593
references: Mol Cells. 2003 Oct 31;16(2):256-9
references: 14651270
references: Annu Rev Pharmacol Toxicol. 2004;44:371-97
references: 14744251
references: Neuroscience. 2004;123(4):867-74
references: 14751280
references: Br J Pharmacol. 2004 Jun;142(3):576-84
references: 15148257
references: J Pharmacol Exp Ther. 2004 Jul;310(1):159-68
references: 15010502
references: J Gen Physiol. 1977 Apr;69(4):497-515
references: 300786
references: Biochim Biophys Acta. 1977 Nov 14;472(3-4):373-98
references: 334262
references: Eur J Pharmacol. 1989 Aug 29;167(3):419-22
references: 2553444
references: J Auton Nerv Syst. 1992 May 15;38(3):201-8
references: 1613209
references: Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9270-5
references: 8799190
references: J Physiol. 1996 Jul 1;494 ( Pt 1):1-16
references: 8814602
references: Neuroscience. 1998 Mar;83(2):633-43
references: 9460769
references: J Neurophysiol. 1998 Apr;79(4):1746-54
references: 9535944
references: J Neurosci. 1999 Jun 1;19(11):4644-53
references: 10341262
references: Toxicon. 2005 Mar 15;45(4):431-42
references: 15733564
references: Eur J Pharmacol. 2005 Mar 14;510(3):197-208
references: 15763243
references: J Physiol. 2005 Apr 15;564(Pt 2):437-50
references: 15705651
references: Exp Neurol. 2005 Jun;193(2):437-43
references: 15869946
references: Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9382-7
references: 15964986
references: J Pain. 2006 Jan;7(1 Suppl 1):S31-7
references: 16426999
references: J Pain. 2006 May;7(5 Suppl 3):S1-29
references: 16632328
references: J Physiol. 2006 Oct 1;576(Pt 1):257-67
references: 16857712
references: J Neurosci. 2006 Oct 18;26(42):10847-55
references: 17050722
references: J Neurophysiol. 2007 Feb;97(2):1258-65
references: 17108087
references: Exp Neurol. 2007 May;205(1):92-100
references: 17362934